Clinical Trials · NCT01078545
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Abbott
- Enrollment
- 729
- Start date
- Sep 2008
- Locations
- 143 sites, Poland, Ukraine
- Primary endpoint
- The Change in the International Prostate Symptom Score (IPSS) From Baseline to Month 12. The IPSS Has a Range From 0 to 35.